Invest with Confidence:
- Follow TipRanks' Top Wall Street Analysts to uncover their success rate and average return.
- Join thousands of data-driven investors – Build your Smart Portfolio for personalized insights.
Helius Medical Technologies ( (HSDT) ) just unveiled an update.
Helius Medical Technologies is actively pursuing strategic alternatives to enhance shareholder value amid challenges with CMS pricing determinations for its PoNS device. Having engaged B. Riley Securities as an advisor, the company is exploring options like mergers or sales, while also addressing reimbursement issues to better position its innovative neuromodulation therapy in the market.
For a thorough assessment of HSDT stock, go to TipRanks’ Stock Analysis page.
